Nursing care and patient education for people treated for tuberculosis

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with tuberculosis disease or latent tuberculosis who started anti-tuberculosis drugs less than 3 weeks ago and are followed at the St Antoine hospital.

Age

Older than 18 years

Sex

All sexes

Disease stage

Tuberculosis disease or latent tuberculosis, diagnosed by the IDSA / CDC recommendations.

Earlier treatment

Treatment with anti-tuberculosis drugs must have started less than 3 weeks ago.

Main reasons for not taking part

• Patients under legal protection
• Patients not covered by a social security scheme
• Patients not followed in a participating department of the St Antoine hospital
• Patients who have not signed informed consent

The registry criteria, word for word

What the trial wants to find out

The incidence of tuberculosis has decreased over the last 2 years on the national territory (6.4/100,000 inhabitants) but remains twice as high in Ile de France where it is increasing with an increase of almost 10% in the number of cases. reported between 2015 and 2017 . the notification rate of tuberculosis disease for the year 2020 was 14.3 cases per 100,000 inhabitants (i.e. 1757 cases declared) which is more than double that found at the national level . As the disease is multifocal, patients are likely to be hospitalized in different departments with variable care and compliance support offered. One of the major issues is compliance with treatment. Indeed, INVS data (2008-2014) report a percentage of treatment completed in pulmonary tuberculosis of 73% . Among these cases, 20% had a potentially unfavorable outcome, including 45% lost to follow-up, which creates a risk of relapse and contagiousness for those around them. The latest data reported in 2022 over the period 2014-2018 seem to show an increase in treatment completeness but completeness remains variable from one region to another and from one year to another Using Public Health France data, the investigator were able to collect the proportion of completeness of treatment at Saint Antoine hospital, which is 60% over the period 2014-2016 (Public Health France, unpublished data). In more recent work carried out within the department retrospectively between 2019-2021, the investigator compared treatment outcomes depending on whether or not patients benefit from ETP support and it is 66% among patients without it. benefited, thus confirming the data from Public Health France over a more recent period.. In this context, several other studies have shown the interest of a therapeutic education program on the completeness of the treatment.

The group in the trial

• Patients with TuberculosisTreatment being tested

  Treatment: Transversal therapeutic education